HKSE:02410 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:02410 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. TYK Medicines's net interest income for the three months ended in Dec. 2024 was HK$0.00 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-4.99 Mil.
The historical data trend for TYK Medicines's Net Interest Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TYK Medicines Annual Data | |||||||
Trend | Dec22 | Dec23 | Dec24 | ||||
Net Interest Income | -15.06 | -23.56 | -11.53 |
TYK Medicines Quarterly Data | ||||||||
Dec22 | Mar23 | Jun23 | Dec23 | Mar24 | Jun24 | Dec24 | ||
Net Interest Income | Get a 7-Day Free Trial | -2.31 | - | -2.10 | -2.89 | - |
Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.
Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-4.99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of TYK Medicines's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Nan Jing Yi Da Tou Zi Guan Li You Xian Gong Si | ||
Nan Jing Yi Da Zi Ben Guan Li Qi Ye You Xian He Huo | ||
Jiang Su Yi Da Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si | ||
Wu Yusheng | 2201 Interest of corporation controlled by you | |
Zhu Julia Ming | 2202 Interest of your spouse | |
Zheng Zhou Tai Ji Hong Nuo Yi Yao Gu Fen You Xian Gong Si | 2101 Beneficial owner | |
Zhang Xing Li Yuan Qi Ye Guan Li He Huo Qi Ye You Xian He Huo | 2101 Beneficial owner | |
He Chao | 2201 Interest of corporation controlled by you | |
Bei Jing Hou Ji Jing Qiao Chuang Ye Tou Zi You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Bei Jing Rong Chen Hou Ji Tou Zi Guan Li You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Zhang Xing Xing Zhang Chan Ye Tou Zi He Huo Qi Ye You Xian He Huo | 2101 Beneficial owner |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.